IDYA
Income statement / Annual
Last year (2023), IDEAYA Biosciences, Inc.'s total revenue was $23.39 M,
a decrease of 54.08% from the previous year.
In 2023, IDEAYA Biosciences, Inc.'s net income was -$112.96 M.
See IDEAYA Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$23.39 M
|
$50.93 M
|
$27.94 M
|
$19.54 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$4.01 M |
$2.10 M |
$1.73 M |
$39.70 M |
$1.25 M |
$886,000.00 |
$391,000.00 |
| Gross Profit |
$19.38 M |
$48.83 M |
$26.22 M |
-$20.16 M |
-$1.25 M |
-$886,000.00 |
-$391,000.00 |
| Gross Profit Ratio |
0.83 |
0.96 |
0.94 |
-1.03 |
0 |
0 |
0 |
| Research and Development
Expenses |
$129.51 M
|
$89.54 M
|
$58.16 M
|
$39.70 M
|
$34.32 M
|
$31.75 M
|
$12.38 M
|
| General & Administrative
Expenses |
$28.31 M
|
$23.90 M
|
$20.05 M
|
$15.18 M
|
$9.95 M
|
$4.67 M
|
$2.05 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$28.31 M
|
$23.90 M
|
$20.05 M
|
$15.18 M
|
$9.95 M
|
$4.67 M
|
$2.05 M
|
| Other Expenses |
-$129.51 M |
$0.00 |
$0.00 |
$0.00 |
$8,000.00 |
$77,000.00 |
$2.43 M |
| Operating Expenses |
$157.81 M |
$113.43 M |
$78.21 M |
$54.88 M |
$44.27 M |
$36.42 M |
$14.44 M |
| Cost And Expenses |
$157.81 M |
$113.43 M |
$78.21 M |
$54.88 M |
$44.27 M |
$36.42 M |
$14.44 M |
| Interest Income |
$21.47 M |
$3.85 M |
$506,000.00 |
$849,000.00 |
$2.29 M |
$1.99 M |
$150,000.00 |
| Interest Expense |
$21.47 M |
$3.85 M |
$0.00 |
$849,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$4.01 M
|
$2.10 M
|
$1.73 M
|
$1.38 M
|
$1.25 M
|
$886,000.00
|
$391,000.00
|
| EBITDA |
-$130.42 M
|
-$62.50 M
|
-$50.27 M
|
-$35.34 M
|
-$44.27 M
|
-$35.53 M
|
-$14.05 M
|
| EBITDA Ratio |
-5.58 |
-1.23 |
-1.8 |
-1.81 |
0 |
0 |
0 |
| Operating Income Ratio
|
-5.75
|
-1.23
|
-1.8
|
-1.81
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$21.47 M
|
$3.85 M
|
$506,000.00
|
$849,000.00
|
$2.30 M
|
$77,000.00
|
$2.43 M
|
| Income Before Tax |
-$112.96 M |
-$58.66 M |
-$49.76 M |
-$34.50 M |
-$41.98 M |
-$34.35 M |
-$11.86 M |
| Income Before Tax Ratio
|
-4.83
|
-1.15
|
-1.78
|
-1.77
|
0
|
0
|
0
|
| Income Tax Expense |
$3.84 M |
-$3.85 M |
-$2.23 M |
-$2.23 M |
-$3.53 M |
$2.07 M |
-$150,000.00 |
| Net Income |
-$112.96 M |
-$54.81 M |
-$47.53 M |
-$32.27 M |
-$38.44 M |
-$34.35 M |
-$11.86 M |
| Net Income Ratio |
-4.83 |
-1.08 |
-1.7 |
-1.65 |
0 |
0 |
0 |
| EPS |
-1.96 |
-1.32 |
-1.35 |
-1.31 |
-1.9 |
-2.41 |
-0.83 |
| EPS Diluted |
-1.96 |
-1.32 |
-1.35 |
-1.31 |
-1.9 |
-2.41 |
-0.83 |
| Weighted Average Shares
Out |
$57.52 M
|
$41.44 M
|
$35.25 M
|
$24.72 M
|
$20.23 M
|
$14.24 M
|
$14.24 M
|
| Weighted Average Shares
Out Diluted |
$57.52 M
|
$41.44 M
|
$35.25 M
|
$24.72 M
|
$20.23 M
|
$14.24 M
|
$14.24 M
|
| Link |
|
|
|
|
|
|
|
